stockrowTempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) Return on invested capital
Tempus AI, Inc.'s return on invested capital over the twelve months to 30 September 2026 was −14.4%, up 1.8 percentage points from fiscal 2025 (−16.2%). That is below the Health Information Services industry median of 0.00% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −16.2% | 976.46 |
| FY2024 | −992.7% | (992.66) |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | — |
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| VEEV Veeva Systems Inc. compare | 343.1% |
| DOCS Doximity, Inc. compare | 50.6% |
| BTSG BrightSpring Health Services, Inc. compare | 8.91% |
| HQY HealthEquity, Inc. compare | 8.24% |
| PRVA Privia Health Group, Inc. compare | 7.47% |
| WAY Waystar Holding Corp. compare | 3.33% |
| HNGE Hinge Health Inc. compare | 0.00% |
| TEM Tempus AI, Inc. | −14.4% |
| HTFL Heartflow, Inc. compare | −42.8% |
| Health Information Services industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement